摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Potassium superoxide | 12030-88-5

中文名称
——
中文别名
——
英文名称
Potassium superoxide
英文别名
potassium;molecular oxygen
Potassium superoxide化学式
CAS
12030-88-5
化学式
KO2+
mdl
——
分子量
71.097
InChiKey
CLSKHAYBTFRDOV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.93
  • 重原子数:
    3
  • 可旋转键数:
    0
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    34.1
  • 氢给体数:
    0
  • 氢受体数:
    2

ADMET

毒理性
  • 副作用
Dermatotoxin - 皮肤烧伤。
Dermatotoxin - Skin burns.
来源:Haz-Map, Information on Hazardous Chemicals and Occupational Diseases

反应信息

  • 作为反应物:
    描述:
    Potassium superoxide 、 1-(5-bromopentanoyl)-1,2,3,4-tetrahydroquinoline 、 18-冠醚-6乙醚 、 silica gel 、 二氯甲烷甲醇 作用下, 以 二甲基亚砜 为溶剂, 反应 8.0h, 以methanol, to yield 1-(5-hydroxypentanoyl)-1,2,3,4-tetrahydroquinoline的产率得到1-(5-hydroxypentanoyl)-1,2,3,4-tetrahydroquinoline
    参考文献:
    名称:
    Benzthiazine analogs as antiinflammatory agents
    摘要:
    式为##STR1##及其药学上可接受的酸盐化合物,其中:Z为S;Y为卤素、烷氧基、烷基或二烷基氨基;a为0、1或2;b为2-12的整数,但若b为2或3,则a不能为0,并且进一步规定,若X为OH,则b不能为2-5,若X为--NH.sub.2,则b不能为2-5;而X从下列群组中选择:--OH、OR.sup.1、--NH.sub.2、--NHR.sup.1、NR1/2、##STR2##和--NHCONHR.sup.2,在其中每个R.sup.1分别独立为烷基或环烷基,或在--NR1/2中,两个R.sup.1共同为亚烷基或形成可选地在环N处被烷基或--CH.sub.2 CH.sub.2 OH取代的哌嗪环;而R.sup.2是烷基、环烷基或可选地取代的苯基;具有抗炎性能,并且可用于治疗由炎症和肿胀所特征的疾病。
    公开号:
    US04512990A1
点击查看最新优质反应信息

文献信息

  • Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin
    申请人:Merck & Co., Inc.
    公开号:US05665719A1
    公开(公告)日:1997-09-09
    Compounds of the formula ##STR1## X is --O--, --NH-- and --NR.sup.8 --; Y is --CH.sub.2 --, --CHR.sup.8 -- and --C(R.sup.8).sub.2 --; R.sup.1 is camphor-10-yl, C.sub.1-5 alkoxyl, styryl, hydroxystyryl, furyl, unsubstituted or substituted thienyl, naphthyl, indolyl, tetrahydronaphthyl, unsubstituted, mono- or di-substituted pyridyl, pyrazinyl, unsubstituted or substituted cyclohexyl where the substituent is R.sup.4, and unsubstituted or substituted phenyl where the substituents on phenyl are R.sup.5, R.sup.6 and R.sup.7 ; R.sup.2 is hydrogen, C.sub.1-5 alkoxy, C.sub.1-5 alkyl, amino, C.sub.1-5 alkylcarbonylamino, nitro or halogen; R.sup.3 is hydrogen, C.sub.1-5 alkoxycarbonyl, cyano or carbamoyl; R.sup.4 is one to two of hydrogen, oxo, hydroxy, C.sub.1-5 alkoxy, C.sub.1-5 alkoxycarbonylamino-C.sub.1-5 alkyl and amino-C.sub.1-5 alkyl; R.sup.5, R.sup.6 are each independently selected from hydrogen, halogen, C.sub.1-5 alkyl, hydroxyl and C.sub.1-5 alkoxy; R.sup.7 is ##STR2## W is CO or SO.sub.2 ; and m is an integer from 0 to 1. Such compounds as useful as oxytocin and vasopressin receptor antagonists.
    式为##STR1##的化合物中,X为--O--,--NH--和--NR.sup.8--;Y为--CH.sub.2--,--CHR.sup.8--和--C(R.sup.8).sub.2--;R.sup.1为桉叶酮-10-基,C.sub.1-5烷氧基,苯乙烯基,羟基苯乙烯基,呋喃基,未取代或取代的噻吩基,萘基,吲哚基,四氢萘基,未取代,单取代或双取代的吡啶基,吡嗪基,未取代或取代的环己基,其中取代基为R.sup.4,未取代或取代的苯基,其中苯基上的取代基为R.sup.5,R.sup.6和R.sup.7;R.sup.2为氢,C.sub.1-5烷氧基,C.sub.1-5烷基,氨基,C.sub.1-5烷基羰基氨基,硝基或卤素;R.sup.3为氢,C.sub.1-5烷氧羰基,氰基或氨基甲酰;R.sup.4为氢,氧代,羟基,C.sub.1-5烷氧基,C.sub.1-5烷氧羰基氨基-C.sub.1-5烷基和氨基-C.sub.1-5烷基中的1-2个;R.sup.5,R.sup.6各自独立地选自氢,卤素,C.sub.1-5烷基,羟基和C.sub.1-5烷氧基;R.sup.7为##STR2##W为CO或SO.sub.2;m为0到1的整数。这些化合物可用作催产素和加压素受体拮抗剂。
  • Pyrazolopyrimidines as therapeutic agents
    申请人:——
    公开号:US20040006083A1
    公开(公告)日:2004-01-08
    The present invention provides compounds of Formula I, 1 including pharmaceutically acceptable salts and/or prodrugs thereof, where G, R a , R 2 , and R 3 are defined as described herein.
    本发明提供了一种公式I的化合物,包括其药学上可接受的盐和/或前药,其中G、Ra、R2和R3的定义如本文所述。
  • Naphthoxyalkylamines and related compounds as antiinflammatory agents
    申请人:Syntex (U.S.A.) Inc.
    公开号:US04536503A1
    公开(公告)日:1985-08-20
    Compounds of the formula: ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein; Y is halo, alkoxy, alkyl, or dialkylamino; a is 0, 1 or 2; b is an integer from 2-12 with the proviso that if b is 2 or 3 a cannot be 0; and X is selected from the group consisting of: --OH, OR.sup.1, --NH.sub.2, --NHR.sup.1, NR.sub.2.sup.1, ##STR2## and --NHCONHR.sup.2 in which each R.sup.1 is independently alkyl or cycloalkyl or in --NR.sub.2.sup.1, both R.sup.1 together are alkylene or form a piperazine ring optionally substituted at the ring N by alkyl or --CH.sub.2 CH.sub.2 OH; and R.sup.2 is alkyl, cycloalkyl, or optionally substituted phenyl; have antiinflammatory properties and are useful in the treatment of conditions characterized by inflammation and swelling.
    式为##STR1##的化合物及其药学上可以接受的酸盐,其中:Y为卤素,烷氧基,烷基或二烷基氨基;a为0、1或2;b为2-12的整数,但如果b为2或3,则a不能为0;X选自以下组:--OH、OR.sup.1、--NH.sub.2、--NHR.sup.1、NR.sub.2.sup.1、##STR2##和--NHCONHR.sup.2,在其中每个R.sup.1独立地为烷基或环烷基或在--NR.sub.2.sup.1中,两个R.sup.1一起为亚烷基或形成一个哌嗪环,该环可以选择性地在环N处被烷基或--CH.sub.2 CH.sub.2 OH取代;而R.sup.2为烷基、环烷基或可以选择性地被取代的苯基。这些化合物具有抗炎性能,并且在治疗由炎症和肿胀所特征的疾病方面是有用的。
  • Pyridyloxyalkanoic acid amide derivatives useful as fungicides
    申请人:Whittingham Guy William
    公开号:US20050065032A1
    公开(公告)日:2005-03-24
    Fungicidal compounds of the general formula (I): wherein X and Y are independently H, halo, C 1-8 alkyl, C 3-6 cycloalkyl, C 2-8 alkenyl, C 2-8 alkynyl, C 1-8 alkoxy, C 1-8 alkylthio, nitro, amino, mono- or di-(C 1-6 )alkylamino, mono- or di-(C 2-6 )alkenylamino, mono- or di-(C 2-6 )alkynylamino, formylamino, C 1-4 alkyl(formyl)amino, C 1-4 alkylcarbonylamino, C 1-4 alkyl(C 1-4 alkylcarbonyl)amino, cyano, formyl, C 1-4 alkylcarbonyl, C 1-4 alkoxycarbonyl, aminocarbonyl, mono- or di-(C 1-4 )alkylaminocarbonyl, carboxy, C 1-4 alkylcarbonyloxy, aryl(C 1-4 )alkylcarbonyloxy, C 1-4 alkylsulphinyl, C 1-4 alkylsulphonyl, C 1-4 alkylsulphonyloxy, aryl, heteroaryl, aryloxy, arylthio, heteroaryloxy or heteroarylthio wherein any of the foregoing alkyl, cycloalkyl, alkenyl, alkynyl, aryl, heteroaryl, groups or moieties are optionally substituted; R 1 is phenyl, cyano, C 1-4 alkyl, C 2-4 alkenyl or C 2-4 alkynyl in which the alkyl, alkenyl and alkynyl groups are optionally substituted on their terminal carbon atom with one, two or thre halogen atoms, with a cyano group, with a C 1-4 alkylcarbonyl group, with a C 1-4 alkoxycarbonyl group or with a hydroxy group, or R 1 is alkoxyalkyl, alkylthioalkyl, alkylsulphinylalkyl or alkylsulphonylalkyl in which the total number of carbon atoms is 2 or 3; R 2 is H, C 1-4 alkyl, C 1-4 alkoxymethyl or benzyloxymethyl in which the phenyl ring of the benzyl moiety is optionally substituted with C 1-4 alkoxy; R 3 and R 4 are independently H, C 1-3 alkyl, C 2-3 alkenyl or C 2-3 alkynyl provided that both are not H and that when both are other than H their combined total of carbon atoms does not exceed 4, or R 3 and R 4 join with the carbon atom to which they are attached to form a 3 or 4 membered carbocyclic ring optionally containing one O, S or N atom and optionally substituted with halo or C 1-4 alkyl; and R 5 is halo, C 1-4 alkyl or C 3-4 cycloalkyl in which the alkyl or cycloalkyl group is optionally substituted with halo, hydroxy, C 1-6 alkoxy, C 1-6 alkylthio, cyano, C 1-4 alkylcarbonyloxy, aminocarbonyloxy, mono- or di(C 1-4 )alkylaminocarbonyloxy, or tri(C 1-4 )alkylsilyloxy. The compounds and compositions containing them are especially useful for combating fungal infections of plants.
    通式(I)的杀真菌化合物:其中X和Y独立地为H、卤素、C1-8烷基、C3-6环烷基、C2-8烯基、C2-8炔基、C1-8烷氧基、C1-8烷基硫基、硝基、氨基、单取代或双取代(C1-6)烷基氨基、单取代或双取代(C2-6)烯基氨基、单取代或双取代(C2-6)炔基氨基、甲酰氨基、C1-4烷基(甲酰)氨基、C1-4烷基羰基氨基、C1-4烷基(C1-4烷基羰基)氨基、氰基、甲酰基、C1-4烷基羰基、C1-4烷氧基羰基、氨基羰基、单取代或双取代(C1-4)烷基氨基羰基、羧基、C1-4烷基羰氧基、芳基(C1-4)烷基羰氧基、C1-4烷基亚磺酰基、C1-4烷基磺酰基、C1-4烷基磺酰氧基、芳基、杂芳基、芳氧基、芳硫基、杂芳氧基或杂芳硫基,其中上述任何烷基、环烷基、烯基、炔基、芳基、杂芳基、基团或官能团均可选择性地被取代;R1为苯基、氰基、C1-4烷基、C2-4烯基或C2-4炔基,其中烷基、烯基和炔基基团在其末端碳原子上可选择性地用一个、两个或三个卤素原子、一个氰基、一个C1-4烷基羰基、一个C1-4烷氧基羰基或一个羟基取代,或者R1为烷氧烷基、烷硫烷基、烷亚磺酰烷基或烷磺酰烷基,其中总碳原子数为2或3;R2为H、C1-4烷基、C1-4烷氧甲基或苄氧甲基,其中苄基官能团的苯环可选择性地用C1-4烷氧基取代;R3和R4独立地为H、C1-3烷基、C2-3烯基或C2-3炔基,前提是两者不都为H,且当两者都不为H时,它们的总碳原子数不超过4,或者R3和R4与它们附着的碳原子结合形成一个3或4元环烷基,其中可选择性地含有一个O、S或N原子并可选择性地用卤素或C1-4烷基取代;R5为卤素、C1-4烷基或C3-4环烷基,其中烷基或环烷基基团可选择性地用卤素、羟基、C1-6烷氧基、C1-6烷基硫基、氰基、C1-4烷基羰氧基、氨基羰氧基、单取代或双取代(C1-4)烷基氨基羰氧基或三取代(C1-4)硅烷氧基取代。这些化合物和含有它们的组合物特别适用于防治植物真菌感染。
  • Preparation of sulphoxonium salts
    申请人:Ciba-Geigy Corporation
    公开号:US05576461A1
    公开(公告)日:1996-11-19
    The present invention provides a process for preparing a sulphoxonium salt from the corresponding sulphonium salt which comprises oxidising the sulphonium salt using a peracid, under basic conditions, in a solvent other than a ketone. Some of the sulphoxonium salts are new compounds.
    本发明提供了一种从相应的磺鎓盐制备硫氧鎓盐的方法,包括在碱性条件下使用过氧酸盐在非酮溶剂中氧化磺鎓盐。其中一些硫氧鎓盐是新化合物。
查看更多